Cancer Commons News and Events

Curious Dr. George logo, Cancer Commons logo, and photo of Anthony M. Magliocco, MD, Founder & CEO, Protean BioDiagnostics

NEW Curious Dr. George—Protean BioDiagnostics: One Way to Access Full-Service Precision Oncology Testing

March 12, 2024

Here’s the latest from our Curious Dr. George! Read “Protean BioDiagnostics: One Way to Access Full-Service Precision Oncology Testing” here. The use of advanced molecular testing of various cancers over the last 10-15 years has driven development of the field of precision oncology. Now, many patients with a variety of cancer types can benefit from targeted therapies. However, accessing precision testing and treatment can… Read more »

Curious Dr. George logo, Cancer Commons logo, and photo of David J. Einstein, MD, Assistant Professor of Medicine, Harvard Medical School & Genitourinary Oncologist, Beth Israel Deaconess Medical Center

Curious Dr. George—How a Harvard Oncologist Would Manage His Own Metastatic Kidney Cancer

March 5, 2024

Here’s the latest from our Curious Dr. George! Read “How Would a Harvard Oncologist Manage His Own Metastatic Kidney Cancer?” here. When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks kidney cancer expert David J. Einstein, MD, how he would handle his own hypothetical case of kidney… Read more »

Curious Dr. George logo, Cancer Commons logo, and photo of John H. Strickler, MD, Associate Professor of Medicine, Division

Curious Dr. George—How an Expert Would Manage His Own Stage 4 Pancreatic Cancer: An Update

February 21, 2024

Here’s the latest from our Curious Dr. George! Read “How an Expert Would Manage His Own Stage 4 Pancreatic Cancer: An Update” here. When confronted with a new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Previously, our Curious Dr. George asked John H. Strickler, MD, how he would handle his own hypothetical diagnosis of metastatic pancreatic cancer. Now, Dr.… Read more »

Curious Dr. George logo, Cancer Commons logo, and photo of Al B. Benson III, MD, FACP, FACCC, FASCO

Curious Dr. George—How a Northwestern Professor Would Manage His Own Liver Cancer

February 13, 2024

Here’s the latest from our Curious Dr. George! Read “How Would a Northwestern Professor Manage His Own Liver Cancer?” here. hen facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks liver cancer expert Al B. Benson III, MD, FACP, FACCC, FASCO, how he would handle his own hypothetical… Read more »

Curious Dr. George logo over Cancer Commons logo, with photo of sphygmomanometer and photo of Robert E. Matthews, President and CEO of MediSync (Cincinnati)

Curious Dr. George—Successful Control of High Blood Pressure, a Major Cancer Comorbidity

December 7, 2023

Here’s the latest from our Curious Dr. George! Read “Successful Control of High Blood Pressure, a Major Cancer Comorbidity” here. People with cancer often face additional health conditions, or “comorbidities,” that complicate treatment. High blood pressure, or hypertension, is a major comorbidity that affects many cancer patients. Our Curious Dr. George asks Robert E. Matthews, President and CEO of MediSync (Cincinnati), about how his… Read more »

Curious Dr. George logo, Cancer Commons logo, photo of Stuart L. Marcus, MD, PhD, Founder & Chief Science Officer, SonALAsense

Curious Dr. George—High-Energy Blue Light Powers a Promising New Treatment to Destroy Cancer Cells

November 21, 2023

Here’s the latest from our Curious Dr. George! Read “High-Energy Blue Light Powers a Promising New Treatment to Destroy Cancer Cells” here. A perennial challenge in cancer treatment is figuring out how to kill tumor cells while leaving healthy cells unharmed. Our Curious Dr. George asks Stuart L. Marcus, MD, PhD, founder and Chief Science Officer at SonALAsense, how his company’s light-activated drug treatment addresses… Read more »

Curious Dr. George logo, Cancer Commons logo, photo of Miriam Chickering, RN, BSN, NE-BC, CEO of NextGenU.org

Curious Dr. George—Integrating AI-Generated Learning Materials into Health Professional Education

November 17, 2023

Here’s the latest from our Curious Dr. George! Read “Integrating AI-Generated Learning Materials into Health Professional Education” here. Artificial intelligence (A.I.) is a powerful tool that has made its way into diverse fields—and medical education is no exception. Our Curious Dr. George asks Miriam Chickering, RN, BSN, NE-BC, CEO of NextGenU.org, how the 22-year-old, U.S.-based organization she leads uses A.I. to help create free… Read more »

Curious Dr. George logo, Cancer Commons logo, and photo of Adam Asch, MD, Professor of Medicine; Nancy Johnson Records Chair of Oncology University of Oklahoma College of Medicine

Curious Dr. George—How an Expert Would Manage His Own Acute Myelogenous Leukemia

October 24, 2023

Here’s the latest from our Curious Dr. George! Read “How Would an Expert Manage His Own Acute Myelogenous Leukemia?” here. When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks leukemia expert Adam Asch, MD, how he would handle his own case of acute myelogenous leukemia. Dr. Asch… Read more »

Curious Dr. George logo, Cancer Commons logo, photo of Sarbajit Mukherjee, MD, MS

Curious Dr. George—How an Expert Would Manage His Own Advanced Esophageal Cancer

October 20, 2023

Here’s the latest from our Curious Dr. George! Read “How Would an Expert Manage His Own Advanced Esophageal Cancer?” here. When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks gastrointestinal cancer expert Sarbajit Mukherjee, MD, MS, how he would handle his own case of advanced esophageal cancer.… Read more »

RECURRENT CANCER: Unique Treatment Guidance After Cancer Returns. Webinar recording now available.

Recurrent Cancer: Unique Treatment Guidance After Cancer Returns—Webinar Recording Now Available

June 27, 2023

Cancer Commons’ most recent webinar, Recurrent Cancer: Unique Treatment Guidance After Cancer Returns, was held virtually June 14, 2023. During the presentation, Dennis Watson, VP of Business Development of Travera, provided viewers with information and updates on a cancer therapy guidance test designed to predict which cancer drugs are most likely to be effective for individual cancer patients. Travera’s unique technology now applies to many cancers… Read more »